HEADER IMMUNE SYSTEM 12-JAN-07 2OJE TITLE MYCOPLASMA ARTHRITIDIS-DERIVED MITOGEN COMPLEXED WITH CLASS II MHC TITLE 2 MOLECULE HLA-DR1/HA COMPLEX IN THE PRESENCE OF EDTA COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN COMPND 3 PRECURSOR; COMPND 4 CHAIN: A, E; COMPND 5 FRAGMENT: EXTRACELLULAR DOMAIN, RESIDUES 27-206; COMPND 6 SYNONYM: MHC CLASS II ANTIGEN DRA; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DRB1-1 BETA CHAIN COMPND 10 PRECURSOR; COMPND 11 CHAIN: B, F; COMPND 12 FRAGMENT: EXTRACELLULAR DOMAIN, RESIDUES 30-219; COMPND 13 SYNONYM: MHC CLASS II ANTIGEN DRB1*1, DR-1, DR1; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: HAEMAGGLUTININ PEPTIDE 306-318; COMPND 17 CHAIN: C, G; COMPND 18 FRAGMENT: RESIDUES 306-318; COMPND 19 ENGINEERED: YES; COMPND 20 MOL_ID: 4; COMPND 21 MOLECULE: SUPERANTIGEN; COMPND 22 CHAIN: D, H; COMPND 23 FRAGMENT: RESIDUES 25-238; COMPND 24 SYNONYM: MYCOPLASMA ARTHRITIDIS-DERIVED MITOGEN; COMPND 25 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PLM1; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PLM1; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES; SOURCE 21 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN INFLUENZA VIRUS; SOURCE 22 MOL_ID: 4; SOURCE 23 ORGANISM_SCIENTIFIC: MYCOPLASMA ARTHRITIDIS; SOURCE 24 ORGANISM_TAXID: 2111; SOURCE 25 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 26 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 27 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 28 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 29 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-1 KEYWDS SUPERANTIGEN, MHC, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR H.LI,Y.ZHAO,Y.GUO,Z.LI,L.EISELE,W.MOURAD REVDAT 4 30-AUG-23 2OJE 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 2OJE 1 VERSN REVDAT 2 03-APR-07 2OJE 1 JRNL REVDAT 1 23-JAN-07 2OJE 0 JRNL AUTH H.LI,Y.ZHAO,Y.GUO,Z.LI,L.EISELE,W.MOURAD JRNL TITL ZINC INDUCES DIMERIZATION OF THE CLASS II MAJOR JRNL TITL 2 HISTOCOMPATIBILITY COMPLEX MOLECULE THAT LEADS TO JRNL TITL 3 COOPERATIVE BINDING TO A SUPERANTIGEN. JRNL REF J.BIOL.CHEM. V. 282 5991 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17166841 JRNL DOI 10.1074/JBC.M608482200 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.22 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2671296.250 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.8 REMARK 3 NUMBER OF REFLECTIONS : 40345 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2850 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6318 REMARK 3 BIN R VALUE (WORKING SET) : 0.3330 REMARK 3 BIN FREE R VALUE : 0.3980 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 443 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.019 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9872 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 118 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.73000 REMARK 3 B22 (A**2) : 13.74000 REMARK 3 B33 (A**2) : -7.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.49 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.58 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.280 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.280 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.840 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.990 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 18.64 REMARK 3 REMARK 3 NCS MODEL : CONSTR REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ION.TOP REMARK 3 TOPOLOGY FILE 3 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2OJE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000041209. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JUN-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40345 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 40.220 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.8 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.12400 REMARK 200 R SYM (I) : 12.4000 REMARK 200 FOR THE DATA SET : 17.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.56300 REMARK 200 R SYM FOR SHELL (I) : 56.3000 REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1R5I REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.7M POTASSIUM SODIUM PHOSPHATE, 0.1M REMARK 280 HEPES, 2 MM EDTA, PH 7.5, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 68.86750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 89.77750 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 89.97600 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 68.86750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 89.77750 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 89.97600 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 68.86750 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 89.77750 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 89.97600 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 68.86750 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 89.77750 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 89.97600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -57.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -67.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXADECAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 49680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 103020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -267.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G, H REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 68.86750 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 89.77750 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 89.97600 REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 -68.86750 REMARK 350 BIOMT2 4 0.000000 -1.000000 0.000000 -89.77750 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 89.97600 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 200 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS G 307 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLU A 179 N ASP A 181 2.14 REMARK 500 O LYS H 143 OH TYR H 194 2.17 REMARK 500 O HOH D 215 O HOH D 233 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NZ LYS E 2 NZ LYS E 2 3655 1.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 51 -12.20 -141.48 REMARK 500 PRO A 102 135.86 -34.74 REMARK 500 PRO A 115 59.30 -69.92 REMARK 500 THR A 129 -61.82 -139.56 REMARK 500 GLU A 158 33.94 -142.80 REMARK 500 GLU A 179 64.85 -172.44 REMARK 500 PHE A 180 -32.47 49.29 REMARK 500 ASN B 33 -97.17 54.85 REMARK 500 THR B 90 -80.52 -115.99 REMARK 500 ASN B 113 -72.31 -58.70 REMARK 500 LYS B 139 -48.99 -138.14 REMARK 500 PRO B 165 106.11 -57.37 REMARK 500 LYS D 10 135.62 -32.41 REMARK 500 ASN D 21 57.28 -145.53 REMARK 500 ALA D 94 -35.30 -33.09 REMARK 500 ASN D 125 74.24 -118.92 REMARK 500 LEU D 200 -52.26 -25.26 REMARK 500 PHE E 51 -12.39 -141.86 REMARK 500 LEU E 99 125.06 -37.60 REMARK 500 PRO E 102 137.77 -36.12 REMARK 500 THR E 129 -60.14 -141.09 REMARK 500 LEU E 144 -167.74 -108.80 REMARK 500 THR E 157 21.89 -74.92 REMARK 500 GLU E 158 32.21 -143.50 REMARK 500 GLU E 179 61.14 -172.71 REMARK 500 PHE E 180 -66.09 43.38 REMARK 500 ASN F 19 71.45 49.17 REMARK 500 ASN F 33 -98.41 55.14 REMARK 500 TYR F 78 -70.48 -111.22 REMARK 500 THR F 90 -80.77 -115.34 REMARK 500 ASN F 113 -74.17 -56.67 REMARK 500 LYS F 139 -50.44 -138.04 REMARK 500 PRO F 165 105.38 -55.88 REMARK 500 LYS H 10 135.39 -32.00 REMARK 500 ASN H 21 58.90 -145.31 REMARK 500 GLU H 71 1.57 -69.47 REMARK 500 ALA H 94 -37.13 -31.64 REMARK 500 ASN H 125 75.75 -117.22 REMARK 500 LEU H 200 -57.68 -17.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 D 214 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 C 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 H 214 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 E 204 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1R5I RELATED DB: PDB REMARK 900 MYCOPLASMA ARTHRITIDIS-DERIVED MITOGEN COMPLEXED WITH CLASS II MHC REMARK 900 MOLECULE HLA-DR1/HA COMPLEX IN THE PRESENCE OF ZINC DBREF 2OJE A 2 181 UNP P01903 2DRA_HUMAN 27 206 DBREF 2OJE E 2 181 UNP P01903 2DRA_HUMAN 27 206 DBREF 2OJE B 1 190 UNP P04229 2B11_HUMAN 30 219 DBREF 2OJE F 1 190 UNP P04229 2B11_HUMAN 30 219 DBREF 2OJE D 0 213 UNP Q48898 Q48898_MYCAT 25 238 DBREF 2OJE H 0 213 UNP Q48898 Q48898_MYCAT 25 238 DBREF 2OJE C 306 318 PDB 2OJE 2OJE 306 318 DBREF 2OJE G 306 318 PDB 2OJE 2OJE 306 318 SEQADV 2OJE MSE A 23 UNP P01903 MET 48 MODIFIED RESIDUE SEQADV 2OJE MSE A 36 UNP P01903 MET 61 MODIFIED RESIDUE SEQADV 2OJE MSE A 73 UNP P01903 MET 98 MODIFIED RESIDUE SEQADV 2OJE MSE E 23 UNP P01903 MET 48 MODIFIED RESIDUE SEQADV 2OJE MSE E 36 UNP P01903 MET 61 MODIFIED RESIDUE SEQADV 2OJE MSE E 73 UNP P01903 MET 98 MODIFIED RESIDUE SEQRES 1 A 180 LYS GLU GLU HIS VAL ILE ILE GLN ALA GLU PHE TYR LEU SEQRES 2 A 180 ASN PRO ASP GLN SER GLY GLU PHE MSE PHE ASP PHE ASP SEQRES 3 A 180 GLY ASP GLU ILE PHE HIS VAL ASP MSE ALA LYS LYS GLU SEQRES 4 A 180 THR VAL TRP ARG LEU GLU GLU PHE GLY ARG PHE ALA SER SEQRES 5 A 180 PHE GLU ALA GLN GLY ALA LEU ALA ASN ILE ALA VAL ASP SEQRES 6 A 180 LYS ALA ASN LEU GLU ILE MSE THR LYS ARG SER ASN TYR SEQRES 7 A 180 THR PRO ILE THR ASN VAL PRO PRO GLU VAL THR VAL LEU SEQRES 8 A 180 THR ASN SER PRO VAL GLU LEU ARG GLU PRO ASN VAL LEU SEQRES 9 A 180 ILE CYS PHE ILE ASP LYS PHE THR PRO PRO VAL VAL ASN SEQRES 10 A 180 VAL THR TRP LEU ARG ASN GLY LYS PRO VAL THR THR GLY SEQRES 11 A 180 VAL SER GLU THR VAL PHE LEU PRO ARG GLU ASP HIS LEU SEQRES 12 A 180 PHE ARG LYS PHE HIS TYR LEU PRO PHE LEU PRO SER THR SEQRES 13 A 180 GLU ASP VAL TYR ASP CYS ARG VAL GLU HIS TRP GLY LEU SEQRES 14 A 180 ASP GLU PRO LEU LEU LYS HIS TRP GLU PHE ASP SEQRES 1 B 190 GLY ASP THR ARG PRO ARG PHE LEU TRP GLN LEU LYS PHE SEQRES 2 B 190 GLU CYS HIS PHE PHE ASN GLY THR GLU ARG VAL ARG LEU SEQRES 3 B 190 LEU GLU ARG CYS ILE TYR ASN GLN GLU GLU SER VAL ARG SEQRES 4 B 190 PHE ASP SER ASP VAL GLY GLU TYR ARG ALA VAL THR GLU SEQRES 5 B 190 LEU GLY ARG PRO ASP ALA GLU TYR TRP ASN SER GLN LYS SEQRES 6 B 190 ASP LEU LEU GLU GLN ARG ARG ALA ALA VAL ASP THR TYR SEQRES 7 B 190 CYS ARG HIS ASN TYR GLY VAL GLY GLU SER PHE THR VAL SEQRES 8 B 190 GLN ARG ARG VAL GLU PRO LYS VAL THR VAL TYR PRO SER SEQRES 9 B 190 LYS THR GLN PRO LEU GLN HIS HIS ASN LEU LEU VAL CYS SEQRES 10 B 190 SER VAL SER GLY PHE TYR PRO GLY SER ILE GLU VAL ARG SEQRES 11 B 190 TRP PHE ARG ASN GLY GLN GLU GLU LYS ALA GLY VAL VAL SEQRES 12 B 190 SER THR GLY LEU ILE GLN ASN GLY ASP TRP THR PHE GLN SEQRES 13 B 190 THR LEU VAL MET LEU GLU THR VAL PRO ARG SER GLY GLU SEQRES 14 B 190 VAL TYR THR CYS GLN VAL GLU HIS PRO SER VAL THR SER SEQRES 15 B 190 PRO LEU THR VAL GLU TRP ARG ALA SEQRES 1 C 13 PRO LYS TYR VAL LYS GLN ASN THR LEU LYS LEU ALA THR SEQRES 1 D 214 SER MET LYS LEU ARG VAL GLU ASN PRO LYS LYS ALA GLN SEQRES 2 D 214 LYS HIS PHE VAL GLN ASN LEU ASN ASN VAL VAL PHE THR SEQRES 3 D 214 ASN LYS GLU LEU GLU ASP ILE TYR ASN LEU SER ASN LYS SEQRES 4 D 214 GLU GLU THR LYS GLU VAL LEU LYS LEU PHE LYS LEU LYS SEQRES 5 D 214 VAL ASN GLN PHE TYR ARG HIS ALA PHE GLY ILE VAL ASN SEQRES 6 D 214 ASP TYR ASN GLY LEU LEU GLU TYR LYS GLU ILE PHE ASN SEQRES 7 D 214 MET MET PHE LEU LYS LEU SER VAL VAL PHE ASP THR GLN SEQRES 8 D 214 ARG LYS GLU ALA ASN ASN VAL GLU GLN ILE LYS ARG ASN SEQRES 9 D 214 ILE ALA ILE LEU ASP GLU ILE MET ALA LYS ALA ASP ASN SEQRES 10 D 214 ASP LEU SER TYR PHE ILE SER GLN ASN LYS ASN PHE GLN SEQRES 11 D 214 GLU LEU TRP ASP LYS ALA VAL LYS LEU THR LYS GLU MET SEQRES 12 D 214 LYS ILE LYS LEU LYS GLY GLN LYS LEU ASP LEU ARG ASP SEQRES 13 D 214 GLY GLU VAL ALA ILE ASN LYS VAL ARG GLU LEU PHE GLY SEQRES 14 D 214 SER ASP LYS ASN VAL LYS GLU LEU TRP TRP PHE ARG SER SEQRES 15 D 214 LEU LEU VAL LYS GLY VAL TYR LEU ILE LYS ARG TYR TYR SEQRES 16 D 214 GLU GLY ASP ILE GLU LEU LYS THR THR SER ASP PHE ALA SEQRES 17 D 214 LYS ALA VAL PHE GLU ASP SEQRES 1 E 180 LYS GLU GLU HIS VAL ILE ILE GLN ALA GLU PHE TYR LEU SEQRES 2 E 180 ASN PRO ASP GLN SER GLY GLU PHE MSE PHE ASP PHE ASP SEQRES 3 E 180 GLY ASP GLU ILE PHE HIS VAL ASP MSE ALA LYS LYS GLU SEQRES 4 E 180 THR VAL TRP ARG LEU GLU GLU PHE GLY ARG PHE ALA SER SEQRES 5 E 180 PHE GLU ALA GLN GLY ALA LEU ALA ASN ILE ALA VAL ASP SEQRES 6 E 180 LYS ALA ASN LEU GLU ILE MSE THR LYS ARG SER ASN TYR SEQRES 7 E 180 THR PRO ILE THR ASN VAL PRO PRO GLU VAL THR VAL LEU SEQRES 8 E 180 THR ASN SER PRO VAL GLU LEU ARG GLU PRO ASN VAL LEU SEQRES 9 E 180 ILE CYS PHE ILE ASP LYS PHE THR PRO PRO VAL VAL ASN SEQRES 10 E 180 VAL THR TRP LEU ARG ASN GLY LYS PRO VAL THR THR GLY SEQRES 11 E 180 VAL SER GLU THR VAL PHE LEU PRO ARG GLU ASP HIS LEU SEQRES 12 E 180 PHE ARG LYS PHE HIS TYR LEU PRO PHE LEU PRO SER THR SEQRES 13 E 180 GLU ASP VAL TYR ASP CYS ARG VAL GLU HIS TRP GLY LEU SEQRES 14 E 180 ASP GLU PRO LEU LEU LYS HIS TRP GLU PHE ASP SEQRES 1 F 190 GLY ASP THR ARG PRO ARG PHE LEU TRP GLN LEU LYS PHE SEQRES 2 F 190 GLU CYS HIS PHE PHE ASN GLY THR GLU ARG VAL ARG LEU SEQRES 3 F 190 LEU GLU ARG CYS ILE TYR ASN GLN GLU GLU SER VAL ARG SEQRES 4 F 190 PHE ASP SER ASP VAL GLY GLU TYR ARG ALA VAL THR GLU SEQRES 5 F 190 LEU GLY ARG PRO ASP ALA GLU TYR TRP ASN SER GLN LYS SEQRES 6 F 190 ASP LEU LEU GLU GLN ARG ARG ALA ALA VAL ASP THR TYR SEQRES 7 F 190 CYS ARG HIS ASN TYR GLY VAL GLY GLU SER PHE THR VAL SEQRES 8 F 190 GLN ARG ARG VAL GLU PRO LYS VAL THR VAL TYR PRO SER SEQRES 9 F 190 LYS THR GLN PRO LEU GLN HIS HIS ASN LEU LEU VAL CYS SEQRES 10 F 190 SER VAL SER GLY PHE TYR PRO GLY SER ILE GLU VAL ARG SEQRES 11 F 190 TRP PHE ARG ASN GLY GLN GLU GLU LYS ALA GLY VAL VAL SEQRES 12 F 190 SER THR GLY LEU ILE GLN ASN GLY ASP TRP THR PHE GLN SEQRES 13 F 190 THR LEU VAL MET LEU GLU THR VAL PRO ARG SER GLY GLU SEQRES 14 F 190 VAL TYR THR CYS GLN VAL GLU HIS PRO SER VAL THR SER SEQRES 15 F 190 PRO LEU THR VAL GLU TRP ARG ALA SEQRES 1 G 13 PRO LYS TYR VAL LYS GLN ASN THR LEU LYS LEU ALA THR SEQRES 1 H 214 SER MET LYS LEU ARG VAL GLU ASN PRO LYS LYS ALA GLN SEQRES 2 H 214 LYS HIS PHE VAL GLN ASN LEU ASN ASN VAL VAL PHE THR SEQRES 3 H 214 ASN LYS GLU LEU GLU ASP ILE TYR ASN LEU SER ASN LYS SEQRES 4 H 214 GLU GLU THR LYS GLU VAL LEU LYS LEU PHE LYS LEU LYS SEQRES 5 H 214 VAL ASN GLN PHE TYR ARG HIS ALA PHE GLY ILE VAL ASN SEQRES 6 H 214 ASP TYR ASN GLY LEU LEU GLU TYR LYS GLU ILE PHE ASN SEQRES 7 H 214 MET MET PHE LEU LYS LEU SER VAL VAL PHE ASP THR GLN SEQRES 8 H 214 ARG LYS GLU ALA ASN ASN VAL GLU GLN ILE LYS ARG ASN SEQRES 9 H 214 ILE ALA ILE LEU ASP GLU ILE MET ALA LYS ALA ASP ASN SEQRES 10 H 214 ASP LEU SER TYR PHE ILE SER GLN ASN LYS ASN PHE GLN SEQRES 11 H 214 GLU LEU TRP ASP LYS ALA VAL LYS LEU THR LYS GLU MET SEQRES 12 H 214 LYS ILE LYS LEU LYS GLY GLN LYS LEU ASP LEU ARG ASP SEQRES 13 H 214 GLY GLU VAL ALA ILE ASN LYS VAL ARG GLU LEU PHE GLY SEQRES 14 H 214 SER ASP LYS ASN VAL LYS GLU LEU TRP TRP PHE ARG SER SEQRES 15 H 214 LEU LEU VAL LYS GLY VAL TYR LEU ILE LYS ARG TYR TYR SEQRES 16 H 214 GLU GLY ASP ILE GLU LEU LYS THR THR SER ASP PHE ALA SEQRES 17 H 214 LYS ALA VAL PHE GLU ASP MODRES 2OJE MSE A 23 MET SELENOMETHIONINE MODRES 2OJE MSE A 36 MET SELENOMETHIONINE MODRES 2OJE MSE A 73 MET SELENOMETHIONINE MODRES 2OJE MSE E 23 MET SELENOMETHIONINE MODRES 2OJE MSE E 36 MET SELENOMETHIONINE MODRES 2OJE MSE E 73 MET SELENOMETHIONINE HET MSE A 23 8 HET MSE A 36 8 HET MSE A 73 8 HET MSE E 23 8 HET MSE E 36 8 HET MSE E 73 8 HET PO4 C 202 5 HET PO4 D 214 5 HET PO4 E 204 5 HET PO4 H 214 5 HETNAM MSE SELENOMETHIONINE HETNAM PO4 PHOSPHATE ION FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 9 PO4 4(O4 P 3-) FORMUL 13 HOH *118(H2 O) HELIX 1 1 LEU A 45 ARG A 50 1 6 HELIX 2 2 GLU A 55 SER A 77 1 23 HELIX 3 3 THR B 51 LEU B 53 5 3 HELIX 4 4 GLY B 54 SER B 63 1 10 HELIX 5 5 GLN B 64 TYR B 78 1 15 HELIX 6 6 TYR B 78 GLU B 87 1 10 HELIX 7 7 SER B 88 THR B 90 5 3 HELIX 8 8 THR D 25 ASN D 34 1 10 HELIX 9 9 GLU D 43 ASN D 67 1 25 HELIX 10 10 GLU D 71 GLU D 93 1 23 HELIX 11 11 ASN D 96 GLN D 124 1 29 HELIX 12 12 ASN D 125 LEU D 146 1 22 HELIX 13 13 GLU D 157 GLY D 168 1 12 HELIX 14 14 ASP D 170 LEU D 176 1 7 HELIX 15 15 LEU D 176 GLU D 195 1 20 HELIX 16 16 GLU D 199 SER D 204 1 6 HELIX 17 17 SER D 204 PHE D 211 1 8 HELIX 18 18 LEU E 45 ARG E 50 1 6 HELIX 19 19 GLU E 55 SER E 77 1 23 HELIX 20 20 THR F 51 LEU F 53 5 3 HELIX 21 21 GLY F 54 SER F 63 1 10 HELIX 22 22 GLN F 64 TYR F 78 1 15 HELIX 23 23 TYR F 78 GLU F 87 1 10 HELIX 24 24 SER F 88 THR F 90 5 3 HELIX 25 25 THR H 25 ASN H 34 1 10 HELIX 26 26 GLU H 43 ASN H 67 1 25 HELIX 27 27 GLU H 71 GLU H 93 1 23 HELIX 28 28 ASN H 96 GLN H 124 1 29 HELIX 29 29 ASN H 125 LEU H 146 1 22 HELIX 30 30 GLU H 157 GLY H 168 1 12 HELIX 31 31 ASP H 170 LEU H 176 1 7 HELIX 32 32 LEU H 176 GLU H 195 1 20 HELIX 33 33 GLU H 199 THR H 203 5 5 HELIX 34 34 SER H 204 PHE H 211 1 8 SHEET 1 A 8 GLU A 40 TRP A 43 0 SHEET 2 A 8 ASP A 29 ASP A 35 -1 N HIS A 33 O VAL A 42 SHEET 3 A 8 SER A 19 PHE A 26 -1 N PHE A 26 O ASP A 29 SHEET 4 A 8 HIS A 5 ASN A 15 -1 N ILE A 8 O ASP A 25 SHEET 5 A 8 PHE B 7 PHE B 18 -1 O PHE B 7 N ASN A 15 SHEET 6 A 8 ARG B 23 TYR B 32 -1 O ILE B 31 N GLN B 10 SHEET 7 A 8 GLU B 35 ASP B 41 -1 O GLU B 35 N TYR B 32 SHEET 8 A 8 TYR B 47 ALA B 49 -1 O ARG B 48 N ARG B 39 SHEET 1 B 4 GLU A 88 THR A 93 0 SHEET 2 B 4 ASN A 103 PHE A 112 -1 O ILE A 106 N LEU A 92 SHEET 3 B 4 PHE A 145 PHE A 153 -1 O PHE A 153 N ASN A 103 SHEET 4 B 4 SER A 133 GLU A 134 -1 N SER A 133 O TYR A 150 SHEET 1 C 4 GLU A 88 THR A 93 0 SHEET 2 C 4 ASN A 103 PHE A 112 -1 O ILE A 106 N LEU A 92 SHEET 3 C 4 PHE A 145 PHE A 153 -1 O PHE A 153 N ASN A 103 SHEET 4 C 4 LEU A 138 PRO A 139 -1 N LEU A 138 O ARG A 146 SHEET 1 D 4 LYS A 126 VAL A 128 0 SHEET 2 D 4 ASN A 118 ARG A 123 -1 N ARG A 123 O LYS A 126 SHEET 3 D 4 TYR A 161 GLU A 166 -1 O ARG A 164 N THR A 120 SHEET 4 D 4 LEU A 174 TRP A 178 -1 O TRP A 178 N TYR A 161 SHEET 1 E 4 LYS B 98 SER B 104 0 SHEET 2 E 4 LEU B 114 PHE B 122 -1 O VAL B 116 N TYR B 102 SHEET 3 E 4 PHE B 155 GLU B 162 -1 O PHE B 155 N PHE B 122 SHEET 4 E 4 VAL B 142 SER B 144 -1 N VAL B 143 O MET B 160 SHEET 1 F 4 LYS B 98 SER B 104 0 SHEET 2 F 4 LEU B 114 PHE B 122 -1 O VAL B 116 N TYR B 102 SHEET 3 F 4 PHE B 155 GLU B 162 -1 O PHE B 155 N PHE B 122 SHEET 4 F 4 ILE B 148 GLN B 149 -1 N ILE B 148 O GLN B 156 SHEET 1 G 4 GLN B 136 GLU B 138 0 SHEET 2 G 4 GLU B 128 ARG B 133 -1 N TRP B 131 O GLU B 138 SHEET 3 G 4 VAL B 170 GLU B 176 -1 O GLN B 174 N ARG B 130 SHEET 4 G 4 LEU B 184 ARG B 189 -1 O LEU B 184 N VAL B 175 SHEET 1 H 8 GLU E 40 TRP E 43 0 SHEET 2 H 8 ASP E 29 ASP E 35 -1 N HIS E 33 O VAL E 42 SHEET 3 H 8 SER E 19 PHE E 26 -1 N PHE E 26 O ASP E 29 SHEET 4 H 8 HIS E 5 ASN E 15 -1 N ILE E 8 O ASP E 25 SHEET 5 H 8 PHE F 7 PHE F 18 -1 O PHE F 7 N ASN E 15 SHEET 6 H 8 ARG F 23 TYR F 32 -1 O ILE F 31 N GLN F 10 SHEET 7 H 8 GLU F 35 ASP F 41 -1 O GLU F 35 N TYR F 32 SHEET 8 H 8 TYR F 47 ALA F 49 -1 O ARG F 48 N ARG F 39 SHEET 1 I 4 GLU E 88 THR E 93 0 SHEET 2 I 4 ASN E 103 PHE E 112 -1 O ILE E 106 N LEU E 92 SHEET 3 I 4 PHE E 145 PHE E 153 -1 O PHE E 153 N ASN E 103 SHEET 4 I 4 SER E 133 GLU E 134 -1 N SER E 133 O TYR E 150 SHEET 1 J 4 GLU E 88 THR E 93 0 SHEET 2 J 4 ASN E 103 PHE E 112 -1 O ILE E 106 N LEU E 92 SHEET 3 J 4 PHE E 145 PHE E 153 -1 O PHE E 153 N ASN E 103 SHEET 4 J 4 LEU E 138 PRO E 139 -1 N LEU E 138 O ARG E 146 SHEET 1 K 4 LYS E 126 VAL E 128 0 SHEET 2 K 4 ASN E 118 ARG E 123 -1 N ARG E 123 O LYS E 126 SHEET 3 K 4 TYR E 161 GLU E 166 -1 O ARG E 164 N THR E 120 SHEET 4 K 4 LEU E 174 TRP E 178 -1 O TRP E 178 N TYR E 161 SHEET 1 L 4 LYS F 98 SER F 104 0 SHEET 2 L 4 LEU F 114 PHE F 122 -1 O VAL F 116 N TYR F 102 SHEET 3 L 4 PHE F 155 GLU F 162 -1 O PHE F 155 N PHE F 122 SHEET 4 L 4 VAL F 142 SER F 144 -1 N VAL F 143 O MET F 160 SHEET 1 M 4 LYS F 98 SER F 104 0 SHEET 2 M 4 LEU F 114 PHE F 122 -1 O VAL F 116 N TYR F 102 SHEET 3 M 4 PHE F 155 GLU F 162 -1 O PHE F 155 N PHE F 122 SHEET 4 M 4 ILE F 148 GLN F 149 -1 N ILE F 148 O GLN F 156 SHEET 1 N 4 GLN F 136 GLU F 138 0 SHEET 2 N 4 GLU F 128 ARG F 133 -1 N TRP F 131 O GLU F 138 SHEET 3 N 4 VAL F 170 GLU F 176 -1 O GLN F 174 N ARG F 130 SHEET 4 N 4 LEU F 184 ARG F 189 -1 O LEU F 184 N VAL F 175 SSBOND 1 CYS A 107 CYS A 163 1555 1555 2.03 SSBOND 2 CYS B 15 CYS B 79 1555 1555 2.04 SSBOND 3 CYS B 117 CYS B 173 1555 1555 2.03 SSBOND 4 CYS E 107 CYS E 163 1555 1555 2.04 SSBOND 5 CYS F 15 CYS F 79 1555 1555 2.04 SSBOND 6 CYS F 117 CYS F 173 1555 1555 2.03 LINK C PHE A 22 N MSE A 23 1555 1555 1.33 LINK C MSE A 23 N PHE A 24 1555 1555 1.33 LINK C ASP A 35 N MSE A 36 1555 1555 1.33 LINK C MSE A 36 N ALA A 37 1555 1555 1.33 LINK C ILE A 72 N MSE A 73 1555 1555 1.33 LINK C MSE A 73 N THR A 74 1555 1555 1.33 LINK C PHE E 22 N MSE E 23 1555 1555 1.33 LINK C MSE E 23 N PHE E 24 1555 1555 1.33 LINK C ASP E 35 N MSE E 36 1555 1555 1.33 LINK C MSE E 36 N ALA E 37 1555 1555 1.33 LINK C ILE E 72 N MSE E 73 1555 1555 1.33 LINK C MSE E 73 N THR E 74 1555 1555 1.33 CISPEP 1 ASN A 15 PRO A 16 0 -0.27 CISPEP 2 THR A 113 PRO A 114 0 -0.26 CISPEP 3 TYR B 123 PRO B 124 0 -0.27 CISPEP 4 ASN E 15 PRO E 16 0 0.28 CISPEP 5 THR E 113 PRO E 114 0 -0.10 CISPEP 6 TYR F 123 PRO F 124 0 0.30 SITE 1 AC1 8 ALA A 61 PO4 C 202 LYS C 310 ALA D 11 SITE 2 AC1 8 GLN D 12 HIS D 14 LYS D 113 ASP D 117 SITE 1 AC2 6 GLY A 58 LYS C 307 LYS C 310 LYS D 10 SITE 2 AC2 6 LYS D 113 PO4 D 214 SITE 1 AC3 7 PO4 E 204 LYS G 310 ALA H 11 GLN H 12 SITE 2 AC3 7 HIS H 14 LYS H 113 ASP H 117 SITE 1 AC4 4 GLU E 55 GLY E 58 LYS G 310 PO4 H 214 CRYST1 137.735 179.555 179.952 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007260 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005569 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005557 0.00000